关注
Yi-Jun Wang
Yi-Jun Wang
Harvard Medical School
在 bwh.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Immunogenic effects of chemotherapy-induced tumor cell death
YJ Wang, R Fletcher, J Yu, L Zhang
Genes & diseases 5 (3), 194-203, 2018
2602018
Multidrug resistance proteins (MRPs) and cancer therapy
YK Zhang, YJ Wang, P Gupta, ZS Chen
The AAPS journal 17, 802-812, 2015
2132015
Repositioning of tyrosine kinase inhibitors as antagonists of ATP-binding cassette transporters in anticancer drug resistance
YJ Wang, YK Zhang, RJ Kathawala, ZS Chen
Cancers 6 (4), 1925-1952, 2014
792014
Colorectal cancer prevention: immune modulation taking the stage
R Fletcher, YJ Wang, RE Schoen, OJ Finn, J Yu, L Zhang
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1869 (2), 138-148, 2018
702018
Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: in vitro and in vivo study
YJ Wang, YK Zhang, GN Zhang, SB Al Rihani, MN Wei, P Gupta, ...
Cancer letters 396, 145-154, 2017
682017
Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs
RJ Kathawala, YJ Wang, CR Ashby Jr, ZS Chen
Chinese journal of cancer 33 (5), 223, 2014
662014
Direct tumor killing and immunotherapy through anti-SerpinB9 therapy
L Jiang, YJ Wang, J Zhao, M Uehara, Q Hou, V Kasinath, T Ichimura, ...
Cell 183 (5), 1219-1233. e18, 2020
652020
Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters
YK Zhang, GN Zhang, YJ Wang, BA Patel, TT Talele, DH Yang, ZS Chen
Scientific reports 6 (1), 25694, 2016
652016
In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1
H Zhang, A Patel, SL Ma, XJ Li, YK Zhang, PQ Yang, RJ Kathawala, ...
British journal of pharmacology 171 (24), 5845-5857, 2014
652014
Design and synthesis of human ABCB1 (P-glycoprotein) inhibitors by peptide coupling of diverse chemical scaffolds on carboxyl and amino termini of (S)-valine-derived thiazole …
S Singh, NR Prasad, EE Chufan, BA Patel, YJ Wang, ZS Chen, ...
Journal of medicinal chemistry 57 (10), 4058-4072, 2014
632014
Voruciclib, a potent CDK4/6 inhibitor, antagonizes ABCB1 and ABCG2-mediated multi-drug resistance in cancer cells
P Gupta, YK Zhang, XY Zhang, YJ Wang, KW Lu, T Hall, R Peng, ...
Cellular Physiology and Biochemistry 45 (4), 1515-1528, 2018
622018
Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1
YJ Wang, RJ Kathawala, YK Zhang, A Patel, P Kumar, S Shukla, KL Fung, ...
Biochemical pharmacology 90 (4), 367-378, 2014
612014
β-Elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter
HQ Guo, GN Zhang, YJ Wang, YK Zhang, K Sodani, TT Talele, CR Ashby, ...
Oncology reports 31 (2), 858-866, 2014
582014
Osimertinib (AZD9291), a mutant-selective EGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells
XY Zhang, YK Zhang, YJ Wang, P Gupta, L Zeng, M Xu, XQ Wang, ...
Molecules 21 (9), 1236, 2016
562016
Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: in vitro and in vivo
GN Zhang, YK Zhang, YJ Wang, P Gupta, CR Ashby Jr, S Alqahtani, ...
Cancer letters 424, 19-29, 2018
552018
Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2
DS Wang, A Patel, S Shukla, YK Zhang, YJ Wang, RJ Kathawala, ...
Oncotarget 5 (12), 4529, 2014
462014
Semi-synthetic ocotillol analogues as selective ABCB1-mediated drug resistance reversal agents
YK Zhang, H Zhang, GN Zhang, YJ Wang, RJ Kathawala, R Si, BA Patel, ...
Oncotarget 6 (27), 24277, 2015
442015
BET Inhibitors Potentiate Chemotherapy and Killing of SPOP-Mutant Colon Cancer Cells via Induction of DR5
X Tan, J Tong, YJ Wang, R Fletcher, RE Schoen, J Yu, L Shen, L Zhang
Cancer research 79 (6), 1191-1203, 2019
432019
Exploring naturally occurring ivy nanoparticles as an alternative biomaterial
Y Huang, YJ Wang, Y Wang, S Yi, Z Fan, L Sun, D Lin, N Anreddy, H Zhu, ...
Acta biomaterialia 25, 268-283, 2015
432015
The BTK inhibitor ibrutinib (PCI-32765) overcomes paclitaxel resistance in ABCB1-and ABCC10-overexpressing cells and tumors
H Zhang, A Patel, YJ Wang, YK Zhang, RJ Kathawala, LH Qiu, BA Patel, ...
Molecular cancer therapeutics 16 (6), 1021-1030, 2017
382017
系统目前无法执行此操作,请稍后再试。
文章 1–20